Abstract

Qualys will release fiscal first‑quarter 2026 results on May 5, 2026 Post Market; this preview compiles consensus expectations for revenue and adjusted EPS, reviews last quarter’s performance, and details the key operating drivers and watch items that could influence trading around the print.

Market Forecast

For the current quarter, the market projects revenue of 173.61 million US dollars, implying 10.51% year‑over‑year growth, and adjusted EPS around 1.80, implying 22.84% year‑over‑year growth; EBIT is modeled at 75.58 million US dollars, up 18.16% year‑over‑year. Based on management’s prior update, guidance is for revenue of 172.50–174.50 million US dollars and adjusted EPS of 1.76–1.83, broadly aligned with the current consensus ranges; there is no formal guide for gross margin or net margin, and consensus does not embed explicit margin changes. Within last quarter’s mix, direct revenue represented approximately 50.51% of sales (~88.57 million US dollars) while partnerships contributed ~49.49% (~86.71 million US dollars); management’s pipeline commentary and product cadence point to stable contribution from both channels near term. The most promising vector for incremental expansion, in our view of the product slate, is the risk remediation and automation layer integrated into the platform, supported by the recently introduced AI agent for exploit validation; the direct‑revenue base stood at ~88.57 million US dollars last quarter while overall revenue grew 10.11% year‑over‑year, offering a solid demand baseline for cross‑sell and upsell.

Last Quarter Review

Qualys delivered revenue of 175.28 million US dollars (+10.11% year‑over‑year), a gross profit margin of 83.36%, GAAP net profit attributable to shareholders of 53.15 million US dollars, a net profit margin of 30.32%, and adjusted EPS of 1.87 (+16.88% year‑over‑year). A notable financial highlight was EBIT of 80.13 million US dollars, up 13.28% year‑over‑year and above the quarter’s model, reflecting tight cost control and operating leverage on subscription scale. On the business side, the revenue split remained balanced: direct revenue accounted for ~50.51% of the quarter (~88.57 million US dollars) and partnerships ~49.49% (~86.71 million US dollars), with total revenue advancing 10.11% year‑over‑year as broader platform adoption sustained demand across customer cohorts.

Current Quarter Outlook (with major analytical insights)

Main business: Direct revenue and core platform subscriptions

The central driver this quarter is expected to be the subscription engine tied to the core platform, which showed steady momentum into the December quarter and underpins management’s revenue outlook of 172.50–174.50 million US dollars. Translating that range to year‑over‑year growth implies roughly low‑teens expansion, in line with the 10.51% growth embedded in consensus. The subscription mix lends itself to high visibility, and the prior quarter’s 83.36% gross margin indicates that product efficiency, savings in delivery costs, and support leverage can continue to sustain a high contribution margin even against modest seasonal softness typical in early‑year quarters. On revenue recognition, deferred revenue and billings cadence are often the swing factors, especially as multi‑module deals expand contract scope. Investors will likely parse comments on deal duration, renewal pricing, and attach rates for adjacent modules to gauge whether revenue growth is tracking the midpoint of guidance. Adjusted EPS consensus at ~1.80 assumes operating expenses scale roughly in line with revenue and that gross margins hold within a narrow band; any signal of incremental hiring, R&D acceleration, or go‑to‑market investments could shift the earnings mix even if headline revenue lands as guided. We expect the direct revenue channel to remain near half of the mix, consistent with last quarter’s ~50.51% contribution (~88.57 million US dollars). Within this channel, management’s prior emphasis on multi‑product adoption suggests cross‑module expansion remains a lever for both revenue and retention. The key watch items this quarter are the conversion of new platform modules into paid seats, renewal pricing outcomes in larger customer cohorts, and comments on the pace of expansion among enterprises that started with a single primary use case and are layering additional modules over time.

Most promising business: Risk remediation and automation features (including AI‑assisted exploit validation)

The company’s risk remediation and automation capabilities, recently augmented by an AI agent designed to validate exploitability and streamline mitigation workflows, represent a catalyst for cross‑sell within the existing customer base. While the revenue contribution from these capabilities is not broken out separately, the strategic logic is straightforward: validation of real exploitability can reduce remediation noise and strengthen the value proposition of the broader platform, making add‑on modules easier to justify in budgets. In the near term, we expect revenue impact to be modest but positive, coming from higher attach on new and renewing contracts. What matters for this earnings event is management’s commentary on adoption metrics—such as pilot counts, general availability status across customer tiers, and qualitative feedback on remediation outcomes. If these capabilities show measurable reductions in time to remediation or demonstrable consolidation benefits, that can support upsell motion and deepen the installed base’s spend, feeding through to billings before revenue recognition catches up. Over time, integration of automation into workflows tends to improve renewal durability and expansion patterns, which supports adjusted EPS through operating leverage. Given last quarter’s balanced revenue split—and direct revenue’s ~88.57 million US dollars base—the path to accelerated growth lies in turning new features into consistent attach drivers. We expect commentary to emphasize customer case studies and early enterprise traction, which would help frame the timeline over which the monetization curve steepens. Any indications that attach rates are tracking ahead of internal plans could also affect how investors interpret the full‑year guidance corridor for both revenue and earnings.

Factors most likely to impact the share price this quarter

Guidance quality and tone are likely to be the biggest swing factor for the stock this quarter. The current quarter’s modeled revenue of 173.61 million US dollars and adjusted EPS near 1.80 already sit well inside management’s guidance ranges; a midpoint raise for the second quarter or for the full year could recalibrate expectations, while a maintenance of the range with cautious language might elicit a muted reaction. Investors will also look for signals around billings growth as an early indicator of revenue durability in the back half of the year. Margin commentary will be scrutinized given the prior quarter’s 83.36% gross margin and 30.32% net margin. If management points to continued efficiency in delivery and support, or to cost offsets that preserve margin while investing in R&D and sales capacity, that supports the consensus adjusted EPS trajectory. Conversely, if stepped‑up investment to accelerate the platform roadmap comes through ahead of revenue uplift, the near‑term EPS mix could drift toward the low end of guidance even with revenue on track. Large‑deal velocity and renewal behavior will also matter. The street will likely seek color on expansion from existing enterprise accounts, including the size and duration of multi‑module contracts and any signs of elongation in approval cycles. The company’s prior highlight of healthy demand for platform capabilities suggests stable renewal dynamics, and any incremental commentary on pricing power—especially on multi‑year renewals—would be constructive. Finally, qualitative progress on product launches, particularly the AI‑assisted exploit validation and remediation workflows, could influence sentiment around the sustainability of double‑digit revenue growth and mid‑20% adjusted EPS growth modeled for this quarter.

Analyst Opinions

Across the rating updates and previews reviewed since January 2026, the majority stance is neutral (Hold), with a consistent emphasis on solid execution balanced by valuation and growth normalization concerns. Notable institutions and analysts maintaining Hold or equivalent ratings in recent months include Berenberg Bank (price target 132.00 US dollars), Scotiabank (135.00 US dollars), Piper Sandler (135.00 US dollars), RBC (Sector Perform, 140.00 US dollars), UBS (150.00 US dollars), Needham (Hold), and TD Cowen (145.00 US dollars). Aggregating the available views yields a neutral majority, with the balance of opinions neither skewing bullish nor explicitly bearish; taken together, the stance implies expectations for in‑line results and a focus on guide quality and operating discipline. The neutral consensus centers on a few recurring themes. First, analysts are aligned with management’s revenue guide of 172.50–174.50 million US dollars for the current quarter and see adjusted EPS of 1.76–1.83 as achievable if cost discipline persists and gross margins remain resilient. Second, the platform’s breadth supports cross‑sell potential, but several analysts want to see sustained evidence that new capabilities—such as the AI‑assisted exploit validation agent—translate into higher attach rates and a clearer billings acceleration before shifting to a more constructive stance. Third, valuation sensitivity remains a constraint in many models, with Hold‑rated notes highlighting the need for either a consistent beat‑and‑raise cadence or tangible proof points on product‑led expansion to justify multiple expansion. From a near‑term trading perspective, the neutral cohort is likely to reward a clean print that meets or beats on revenue near 173.61 million US dollars and adjusted EPS around 1.80 while also delivering a confident update on second‑quarter and full‑year trajectories. Should management reaffirm full‑year revenue of 717.00–725.00 million US dollars and indicate that operating margins can be preserved even as product investment ramps, it would address two of the most cited watch items among Hold‑rated notes. Conversely, a cautious tone on billings or a signal that investments will weigh on near‑term margins without a corresponding raise to revenue outlook may reinforce the neutrality of the current stance and cap upside in the short run. In sum, the majority of institutional opinions are neutral and hinge on execution benchmarks: revenue landing inside the guided range, adjusted EPS near the midpoint, and forward‑looking comments that demonstrate the platform’s ability to convert new capabilities into measurable commercial outcomes. With consensus already calling for 10.51% year‑over‑year revenue growth and 22.84% year‑over‑year adjusted EPS growth in the current quarter, incremental upside may depend on whether management pairs an in‑line print with encouraging demand signals, stable renewal metrics, and clearer evidence of attach momentum for risk remediation and automation modules.